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Biotech Innovation in Europe's Food and Drink Processing Industry: 
Promise, Barriers and Exploitation 
 
Jacqueline Senker and Vincent Mangematin 
1 Introduction 
Early optimism about the potential of biotechnology to contribute to "the production of food 
with improved quality and nutritional content" (ACOST, 1990) has waned in the face of 
consumer resistance to the use of genetically modified organisms in food. The European food 
and drink sector has not abandoned biotechnology, however, but it is being very selective in 
its use. Some of the current applications of biotechnology were not recognized in early 
predictions about the application of biotechnology to the food and drink sector. 
 
As general background, this chapter will first briefly review the characteristics of the 
European food and drink industry, including the factors explaining diversity in firms' 
responses to the opportunities for innovation in the sector. This mainly draws on detailed 
research carried out in the 1980s which identified the major trends affecting innovation in the 
industry (Senker, 1987). Much less research was carried out subsequently, and this smaller 
body of research gives no indication that these conditions have changed significantly  
(Mangematin and Mandran, 2001). The next section will discuss the many opportunities for 
product and process innovation in the food and drink industry provided by advances in 
biotechnology. It focuses specifically on biotechnology applications to the food and drink 
sector and excludes those connected with agriculture. The third section will review 
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information about the factors that have promoted and held back the exploitation of 
biotechnology by Europe's food and drink firms. The fourth section will present evidence 
about the industrial exploitation of biotechnology by European agro-food firms. This includes 
results from the European Commission funded European Biotechnology Innovation System 
(EBIS) project1 as well as recent information from two countries (Finland, Ireland) on firms’ 
strategies  to apply biotechnology to the food and drink sector. On the basis of the material 
presented, the conclusion will consider progress in biotechnology innovation in the European 
food and drink industry in the next five to ten years.  
 
2 Background 
2.1 Structure and other Characteristics of the Sector:  
Food products and beverages is the second largest manufacturing sector in the EU, and the 
largest manufacturing sector in Denmark, Greece, Spain, The Netherlands, Portugal and the 
United Kingdom (European Commission, 2003). The European food and drink sector is very 
large in terms of the number of firms as well as the number of employees, as shown in Table 
1. This table also shows that France, Germany, Italy and the UK are the major food and drink 
manufacturing countries in the EU, accounting for approximately two-thirds of production. 
Poland has the largest food and drink sector of the new member states, with production 
totalling over €25 billion in 2002. The Czech Republic, Slovakia, Hungary and Slovenia 
together did not quite match Poland's production (Sausen, 2004). 
                                                 
1 The EBIS project was funded by the European Community under the Targeted Socio-Economic Research 
Programme, contract number SOE1-CT98-1117 (DG12 - SOLS).      
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Table 1: Food and drink sector, companies and employment, 2001 
 Production 
€ billion 
# of firms # of employees 
(000s) 
Austria 11b 1,264b 79b 
Belgium 24b 723 62 
Denmark 17b 450 87b 
Finland 8b 336 34 
France 115c 3,604 392c 
Germany 110 6,035 597 
Greece 5 1,036b 43 
Ireland 15 687 47 
Italy 93 6,800d 268 
Luxembourg 1 226 4b 
The Netherlands 39b 855 147b 
Portugal 10b 1,916d 104b 
Spain 67 3,040 371b 
Sweden 13c 244 53 
UK 98b 2,319 506b 
Europe 15 626 29,635 2,796 
  Note: b more than one employee; c more than three employees;  d more than nine employees. 
  Source: Confederation of the food and drink industries of the EU (CIAA) Website, 
 Statistics and trends, Countries available at: 
 http://www.ciaa.be/uk/library/statistics/countries.htm 
 
Many different product markets comprise the food and drink sector: 
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• Cereal products  
• Beverages  
• Confectionery and snacks 
• Fish and fish products 
• Processed fruits and vegetables  
• Oils and fats 
• Dairy products 
• Meat products 
 
Despite the large number of firms, the sector is dominated by a small number of very large 
multinational corporations (MNCs) like Danone, Diageo, Nestle, Unilever and Heineken, 
which coexist with a large number of small firms. Thus "concentration at the EU level is 
fairly high: on average, the 5 firm concentration ratio is 30%…" (Regional Policy Directorate 
General, 2002) with MNCs dominating many individual product markets. Concentration has 
been explained as a response by food manufacturers to a range of pressures including 
globalisation, a response to growing concentration of food retailers2 and increasing regulation 
of food connected with food safety, health and traceability (EMCC, 2004). Many MNCs have 
diversified and are represented across a range of product markets. Small firms tend to 
specialize in specific product markets and can thrive by responding to demand for specialist 
products in niche markets (e.g. ethnic, organic and vegetarian foods). 
 
                                                 
2 In 2003, the leading 10 European food retailers accounted for 40% of total retail sales (EMCC, 2004) 
 5
Small and medium sized firms continue to co-exist with large multi-national firms in the food 
and drink sector. Different reasons explain this co-existence. Indeed, food processing is 
technologically straightforward and efficiency can be achieved even at a small scale. In 
addition, producers and transformers have to keep close to the source of production and/or to 
their markets. However large firms predominate in sectors such as sugar or vegetable oil 
refining and in instant coffee processing where plant size provides significant economies of 
scale. Mechanisation, batch automation and continuous flow processing have been applied to 
food processing (Wilkinson, 1998), but small and medium sized firms take advantage of the 
fact that current consumer demand for food is influenced more by considerations of quality 
and authentic craft-based production practices than by low-cost or standardisation (Byé, 
1998). 
 
However, the large food and drink MNCs gain economies of scale from sharing a common 
distribution network or from advertising (Horst, 1974). They can also access foreign markets 
through direct investment abroad. Foreign markets present problems for small companies, 
both for those selling perishable or bulky foods and those who find it too costly or difficult to 
adapt their products to satisfy the tastes or eating habits of foreign consumers.  
 
The percentage of firms in the food and drink sector that innovate is high, although they have 
a low research capacity (Christensen et al, 1998). In France, for instance, a survey (1986-90) 
found that 70% of food and drink firms that responded to the Community Innovation Survey 
(CIS), reported innovations but less than 5% of them had internal research capacities 
(Mangematin and Mandran, 2001). The key to competitiveness in the food and drink industry 
is time to market and product costs. Thus, a high level of innovation (according to the CIS 
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definition3) co-exists with a low level of patents, with food technology patents only 
accounting for about 1% of European patent applications (European Patent Office, 2004). 
This finding is not surprising in light of sectoral R&D expenditure, which is often used as an 
indicator of companies' capability to innovate. Traill and Grunert (1997) show that the food 
industry has one of the lowest ratios of R&D expenditure to value added of any industrial 
sector. Furthermore, Galizzi and Venturini (1996) point out that the food industry "is 
characterized by a low R&D intensity, radical innovations are absolutely rare and R&D is 
only a minor component of expenditures for implementing non-price strategies".  
 
There are several reasons for this low R&D intensity.  It is partly related to the innovation 
regime in the food and drink sector: incremental improvements result mainly from know how 
and on-going process improvements rather than from formal R&D. Thus, patenting to protect 
innovations is lower than in other sectors. Food and drink manufacturers mainly benefit from 
innovations protected by trade secrets: unique process plant or complex product formulations 
(e.g. Coca-Cola). Low R&D intensity also results from companies' poor ability to benefit 
from such investment. Unlike the low-volume, high value-added products of the 
pharmaceuticals sector, the food and drink sector is mainly concerned with high-volume, low 
value-added products,4 that have poor prospects for recouping investments in R&D. New 
product development is an expensive and risky business for food manufacturers, undertaken 
in the belief that development and promotion costs plus some element of profit will be earned 
before imitations appear on the market. However, "response time" (the time it takes for 
                                                 
3 The CIS definition of innovation is a new product or process for the firm, a new product or process for the 
market, a combination of a new product and process or an new organisation.  
4The food ingredients subsector (flavourings and colourings) is an exception. It has similar characteristics to the 
pharmaceuticals sector.  
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imitations to appear) is facilitated by the activities of powerful food retailers in sourcing 
“own-label” products and the wide availability of standard process plant and statutory food 
labelling (Senker, 1987). Thirdly, the propensity of SMEs to patent is lower than that of large 
firms  and the sector contains a very high proportion of small firms which target small or 
local markets.  
 
To sum up, the food and drink industry is a mature industry with low margins because of the 
purchasing power of concentrated food retailers. Innovation in the food and drink industry is 
not predominantly science based, and that is why patents are not an appropriate method to 
measure innovativeness in the food and drink sector. It is mainly based on incremental 
improvements and incremental change to product formulation or design. Such innovations, 
based on know how, are not patented as they can be easily imitated (Oxley, 1997).  
2.2 Sources of Innovation:  
Anne Lebars (2001) has identified four sources of innovation for the food and drink sector. 
These are: 
i. Relations with suppliers. Suppliers’ research and/or incremental improvements to 
their products are an important source of innovation in the food and drink sector. 
For instance suppliers make a significant contribution to production plant design to 
reduce costs or improve product quality.  
ii. Quality and regulation. The food and drink sector is highly regulated. Quality or 
sanitary norms may lead to innovation to conform with new standards.5 According 
to firms’ managers, this is a strong incentive to innovate, especially for SMEs; it 
enables them to remain in business. 
                                                 
5 Millstone (1994) has shown that regulation of the food sector both hinders and promotes innovation. 
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iii. Improvements in the knowledge base. Increased knowledge can stimulate 
innovation in food and drink sector, especially for firms undertaking R&D who have 
close links with public sector research.  
iv. The demands of food distributors. Food retailing is highly concentrated in Europe, 
especially in Finland, France, Germany, Sweden and the UK. The specific 
requirements of food retailers provide a strong incentive to innovate. Senker (1986) 
showed that food manufacturing innovation and the direction of innovation in the 
UK was driven by R&D performing multiple food retailers. By giving technical 
advice and the assurance of orders, they had stimulated innovation and lowered the 
entry barriers for suppliers of own-label food products). 
 
2.3 Factors Affecting Firms' Innovative Behaviour:  
Many factors affect the way that food and drink manufacturers respond to opportunities for 
innovation. Part of their response can be explained by the orientation of the companies, as 
presented in the following classification (Burns, 1983):  
 
i. agriculturally-oriented firms either process raw food materials to be suitable for 
further manufacture, for example flour milling and sugar refining, or preserve the 
commodity, for instance by bottling, canning and freezing fruit and vegetables. 
They seek to produce standard products at minimum cost and often rely on by-
products for profitability. Such companies are likely to be interested in process 
innovations that minimize energy costs or reduce the waste of raw materials. 
Innovation may also focus on processing the raw material into its basic 
components (sugars, starches, fats and proteins) so as to produce standardized, 
intermediate products (thickeners, sweeteners, concentrates, flavourings, 
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colourings etc.) with well-defined technological and nutritional characteristics 
(OECD Observer, 1980) for manufacturers of more highly processed foods. 
Agriculturally-oriented companies may also develop product innovations based 
on waste products. 
ii. consumer-oriented firms manufacture more highly processed convenience foods, 
such as breakfast cereals, biscuits, chocolate and sugar confectionery, from 
inputs that are typically produced by agriculturally-oriented firms. Such 
companies are likely to be interested in innovations connected with new 
preservation or packaging techniques that extend shelf-life, or with new process 
technologies that allow them to introduce new consumer products. 
 
Recent studies show that the R&D expenditure of European food manufacturing companies is 
correlated with the development of new products (Traill and Meulenberg, 2002) and that 
product innovations are more important than process innovations in the innovation strategies 
of the largest firms (Arundel et al, 1995). European consumers are conservative about the 
food they choose to eat (Galizzi and Venturini, 1996) and most innovations in the food 
industry tend to be incremental6 rather than radical (Huiban and Bouhsina, 1998; Menrad, 
2004). In other words, consumer unwillingness to accept highly innovative products makes 
food and drink companies unwilling to exploit the opportunities offered by radical 
technologies such as biotechnology. 
 
                                                 
6 Incremental innovations are innovations which are new for the firm but which already exist in the market. 
Radical innovation are innovations that are new for both the firm and the market (OECD, Programme Oslo 
Innovation Workshop 9-10 February 2004) 
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3 Potential of Biotechnology for the Food and Drink Sector 
Biotechnology has been defined as "the application of biological organisms, systems and 
processes to the manufacturing or service industries" (ACARD/ABRC/The Royal Society, 
1980). This definition has been further refined in terms of its application to the food sector as 
"the use of living cells, or parts of them, to produce or modify foods and food ingredients" 
(Jeffcoat, 1999). Traditional applications of biotechnology in the food and drink sector 
include plant and animal breeding, cheese- and yoghurt-making and the use of yeast to leaven 
bread and ferment alcohol. Second-generation food biotechnology is based on attempts to 
screen and categorize enzymes and micro-organisms in the natural environment and exploit 
those with useful applications. It includes the identification of enzymes for use as food 
ingredients and the long-standing use of microbial fermentration to manufacture citric acid, 
glutamic acid and nucleotides for use as flavour enhancers. Similarly, micro-organisms are 
used for the production of mycoprotein.7 Modern biotechnology dates from the early 1970s 
and is based on scientific breakthroughs in genetics and molecular biology (recombinant 
DNA and monoclonal antibodies). It enables the manipulation of genes and alterations to the 
genetic structure of cells.  
 
Jeffcoat (1999) differentiates the application of traditional biotechnology from those of 
modern biotechnology; the former focuses on making products using fermentation 
technology, while the latter is directed at tailoring ingredients for a specific end-use. Modern 
biotechnology applied to food is based on a combination of molecular genetics, applied 
enzymology and fermentation technology. Jeffcoat (1999), Hüsing et al (1999) and Menrad et 
                                                 
7 Mycoprotein (brand name Quorn) was developed by Rank Hovis McDougall when searching for a cheap, 
vegetarian protein food with which to feed the Third World.  
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al (1999) identify six areas where there are opportunities for applying biotechnology to the 
food sector: 
i. Control of raw materials through their manipulation and selection in plants or 
animals; 
ii. Modification of raw materials to improve their performance; 
iii. Production of novel ingredients; 
iv. Modified process plant to reduce environmental burden and improve efficiency 
and quality; and 
v. Production of new diagnostic and analytical tools. 
 
3.1  Control of raw materials8: The major components of raw materials for food production 
are proteins, fats and carbohydrates and the minor components, often termed additives, 
include colours, stabilizers, flavours, enzymes, preservatives, vitamins and thickeners. Better 
control of raw materials has many advantages including influencing the flavour of the food to 
be produced, standardising plants to produce a high level of the component required (e.g. oil 
in seeds) so as to reduce the need for purification and downstream processing, and lessening 
the need for chemical processing to produce intermediate components with the desired 
characteristics. Better control of raw materials is also achieved through plant tissue culture to 
produce flavours and spices (e.g. mint oil, saffron, ginger).  
 
3.2  Modifying raw materials and producing novel ingredients:9 There is the potential for 
micro-organisms or isolated enzymes to modify the raw materials from plants and animals to 
produce novel ingredients. For instance a process using enzymes has been developed to 
                                                 
8 Mainly based on Jeffcoat (1999) 
9 Mainly based on Jeffcoat (1999) 
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produce a natural emulsifier from egg yolks that has enhanced heat stability. Such 
applications are still held back by lack of scientific knowledge and skills, low cost enzymes 
and appropriate processing systems. Novel ingredients can also be produced by fermentation. 
There has been a long trend to replace natural ingredients with a broad range of flavours 
produced by fermentation. Recombinant DNA can also be used to increase the production of 
scarce enzymes from microbial sources.  For instance, there is a shortage of the enzyme that 
clots cheese, commonly known as rennin. It is usually obtained from calves' stomachs, but 
Gist-Brocades has genetically modified yeast to produce this enzyme.10  
 
3.3  Process plant applications: The large amounts of waste products generated by the food 
and drink manufacturing process cause an environmental burden. The application of 
biotechnology to the processing system could alleviate this problem and biotechnology could 
also be used to convert waste products into marketable products. One engineering company 
has cooperated with an enzyme firm and a food company to develop plant using biocatalytic 
processes for the processing of seed oil. This has led to a substantial reduction in waste, as 
well as savings in the use of toxic processing aids. Other seed oil companies in several 
countries have also implemented this process. To date, the introduction of process-integrated 
biocatalysis has been initiated by firms’ interest in improving process plant efficiency, not in 
meeting environmental standards for reducing pollution; existing technology enables them to 
comply with these standards (Hüsing et al, 1999).  
 
3.4  Diagnostic and analytical tools11: There is great demand for analytical and diagnostic 
tools in the food and drink sector to deal with a wide variety of different applications. In the 
                                                 
10 It is sold as Maxiren® see http://www.dsm.com/dfs/dairy/products/enzymes/~en/index.pl?f=maxiren.htm 
11 Based on Menrad et al (1999). 
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past these tools were based on physical and chemical methods. New methods for analysis and 
diagnosis based on biotechnology have supplemented, and even replaced conventional 
methods. The new  biotechnology methods include: 
 
i. Enzymatic assays, including bioluminescence to detect dirt and stains on food-
processing equipment and other surfaces, so as to improve cleaning efficiency and 
the hygiene of processing equipment. 
ii. Biosensors for food processing mainly focus on the determination of carbohydrates, 
mostly glucose. However, many promising biosensors developed by academics have 
failed to live up to their promise when put in contact with food samples. This is 
thought to be due to the high complexity of the samples. 
iii. Immunoassays based on monoclonal antibodies that are able to detect pesticides or 
dangerous food pathogens. 
iv. Nucleic acid based assays are able to detect specific DNA sequence material. They 
have numerous applications including monitoring infectious agents in crop 
production, animal husbandry and food processing; controlling the identity of 
production strain and starter cultures and identifying the origin of raw materials and 
components of processed food. 
 
A recent Delphi survey investigated which applications of modern biotechnology to food 
production and food processing might come to fruition in the future. The applications with 
the brightest prospects are connected with diagnostics, and with the use of genetic 
engineering to produce enzymes. With regard to the former,  they suggest that: 
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"technologies such as DNA chips, presently at the threshold of revolutionizing 
analytics and diagnostics in human health care, can also be transferred to the Agro-
Food sector. This may result in the broad application of inexpensive, easy-to-use and 
automated assays in the Agro-Food sector" (Menrad et al, 1999).  
 
In relation to food enzymes they note strategic decisions by leading producers of enzymes to 
use genetic engineering as a core technology. They conclude that most food enzymes will be 
produced by organisms in the "near to mid-term future", that the time to market for new 
enzymes will be drastically shortened, and there will be a much larger variety of enzymes 
commercially available  than previously (Menrad et al, 1999). 
 
This brief review of the potential applications of biotechnology to the food and drink sector 
shows that there are innovation opportunities for both mature and new product sectors. Many 
of the opportunities seem more relevant for application by agriculturally-orientated firms than 
those in consumer-orientated sectors (see section 1.3).  However, most of these opportunities 
are related to various suppliers in the food chain, rather than directly to food and drink 
manufacturers. For instance, changes to food raw materials may rely on the activities of the 
seeds industry; the development of new food ingredients, such as enzymes, may depend 
primarily on fine chemical companies; similarly, innovation to process plant is connected to 
initiatives by its manufacturers or to those of consultant engineers providing specialized 
equipment. Diagnostic tools may come from research equipment suppliers. Food packaging 
firms may also find ways to integrate biotechnology in their products, for instance to indicate 
food spoilage. However, some large MNCs may have subsidiary companies involved in some 
of these activities, or could cooperate with their suppliers in the development of such 
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innovations. Indeed, an analysis of the patents of food and drink multinationals shows that 
they have significant in-house capabilities in biotechnology (Alfranca et al, 2004).  
 
The ideal model for biotechnology innovation has been based on practice in the R&D 
intensive pharmaceutical sector. One of its most striking characteristics is the wide 
pervasiveness of networking between dedicated biotechnology firms (DBFs), multinational 
companies and academic researchers, or distributed innovation (Coombes and Metcalfe, 
2000). The example of lactic acid bacteria patents (where Europe has a dominant position) 
shows that DBFs play a negligible role in biotechnology innovation in food science. Most 
R&D connected with these patents is collaboratively organized, with a single multinational 
company12 collaborating with one or several public research organisations.13 The firms 
involved have competence in relevant biotechnology and the research knowledge that allows 
them to collaborate with external research partners. Moreover this distributed innovation 
system is based on incumbents (the multinational food companies) recognising and assessing 
the ways in which biotechnology can augment their existing technologies. The mandate of 
government food research institutes, involved in food safety, food quality and the formulation 
of standards and regulation, has provided them with the specialized knowledge that enables 
them to contribute to defining relevant research to be undertaken. According to Valentin and 
Jenssen (2003), university scientists are ill equipped to identify relevant research questions in 
agro-food production as this mainly concerns problems of “know-how”, but they are able to 
contribute problem-solving skills. However, exploiting biotechnology opportunities confronts 
                                                 
12 This includes both specialized food ingredients suppliers (Chr. Hansen of Denmark) and very large, 
differentiated multinational companies like Unilever and Nestlé. 
13 As pointed out by Kalaitzandonakes (2000) public investment in agrobiotechnology is high and compensates 
for the lack of private investment. 
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many barriers, even for sophisticated MNCs. These difficulties are discussed in the next 
section. 
 
4 Barriers to Biotechnology Innovation  
Lack of confidence in receiving economic benefits from an innovation is the major barrier to 
the introduction of new technologies by firms’. Conversely, the promise of quick profits from 
investment in a new technology acts as an incentive for innovation. Companies do not 
anticipate that biotechnology innovation will prove beneficial to them for many reasons. It 
involves costly R&D and there are long delays between developing products and bringing 
them to market, caused by the need to meet regulatory requirements. Moreover, food and 
drink processing firms may not realize the full benefit of biotechnology innovations when 
they are produced by dedicated firms with strong appropriation regimes based on patents. 
Thus, dedicated biotechnology firms are more likely to benefit from innovative activity, not 
the food firms which take risks in applying their innovations. Secondly, the bargaining power 
of large scale retailers strongly influences product prices. Food and drink firms do not 
anticipate being able to negotiate increased prices for innovative products that lack obvious 
value for the consumer. 
 
Another barrier to the introduction of new technologies by firms is their tendency to base 
innovation on technologies that are familiar to them.  Indeed, it is extremely difficult for them 
to extend their existing knowledge base into new areas of innovative activity. The firms that 
do undertake in-house R&D often focus on the quality, variability or hygiene of the raw 
materials for the specialized sector in which they operate (e.g. dairy products, or meat 
products). They do not have any in-house competence to exploit advances in biotechnology, 
and there are no incentives for them to develop such competence. Menrad et al (1999) note 
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that this lack of expertise in European small and medium sized food firms limits their demand 
for biotechnology processes and methods based on new enzymes or diagnostic tools, and this 
could have negative effects on  the willingness of their suppliers to innovate.  
 
Moreover, firms are also reluctant to introduce radical process innovations when the existing 
manufacturing facilities are functioning well, because of the high cost, long pay-back period 
and difficulties for its integration with existing plant, processes and routines (Hüsing et al, 
1999). Companies’ uncertainty about the economic value of investing in biotechnology has 
been exacerbated by public opposition to genetically modified organisms (GMOs) in food. 
The public is worried about the health and safety implications of the new technology, as well 
as the ethical issues raised. Regulatory delays and uncertainty, and public rejection of GMO 
food are discussed below. 
 
A complex system of regulation ensures the safety and quality of the products manufactured 
by the food and drink industry. It is complex because there are numerous ways in which food 
can be harmful to consumers. These include the adulteration of food or drink by "fungal 
mycotoxins, hazardous bacteria, poisonous chemical additives or toxic pesticides, or which 
has not been handled or processed safely" (Millstone, 1994). A wide range of different types 
of regulatory instruments are used, and differ from country to country. Regulation in some 
countries, for instance, may cover matters like minimum standards of staff training, or 
registration of premises on which foods are processed, stored or sold. The regulation of novel 
food products14 is even more complicated, and these procedures cover genetically modified 
                                                 
14 The author was told by a former Research Director of the company that developed Quorn, that it would never 
have begun the project if it had been aware of the amount of work and time demanded to provide the 
documentation to meet regulatory standards for novel food products. 
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foods. Regulation covers manufacturing processes and demands rigorous assessment of 
toxicological, nutritional, compositional and other relevant data. Where the new food is 
proved to be substantially equivalent to one already on the market, it is not regarded as a 
novel product.  
 
There are several reasons why the regulation of novel foods deters innovation: the cost of 
compliance is very high, there are long delays in copleting the regulatory process and there is 
great uncertainty about if or when returns can be realized on investments in innovation. The 
Novel Food Regulations were introduced by the EU in 1997. They cover food that contains 
GMOs, consists of GMOs or is produced from GMOs but does not contain them. Labelling of 
GMOs is mandatory to give European consumers the right to choose whether or not they 
wish to buy foods containing GMOs.15 New regulations for the labelling and traceability of 
genetically modified (GM) food came into force throughout the EC in 2004.16 These 
regulations are intended to facilitate the commercialization of GM foods. Member states have 
the right to define penalties for infringements, but many have not yet determined such 
penalties or enforcement procedures. In addition, the regulations will be phased in gradually 
because of the differing processing times and life cycles of the products concerned. Greater 
harmonization may await a new regulation for food and feed control systems, unlikely to 
come into force until 2006 (Anon, 2004).  
 
Even before these regulations were first proposed in 2001, other events created a seemingly 
insurmountable barrier to biotechnology innovation in the food and drink sector. Monsanto 
                                                 
15 The threshold of foreign DNA triggering mandatory labelling is 1%. 
16 See http://europa.eu.int/comm/dgs/health_consumer/library/press/press298_en.pdf for detailed information on 
these regulations. 
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introduced its GM “Roundup Ready” soyabean to the European market in 1996, at a time 
when there were no specific regulations in place for genetically modified foods. These 
soyabeans came from plants that had been modified to make them herbicide resistance. The 
GM soyabeans met with strong public opposition, although the strength of public opposition 
varied from country to country. The unclear regulatory environment for GM food was 
perceived as an institutional vacuum and it was filled by private initiatives. In response to 
public concern about GM, food retailers and food manufacturers quickly moved to establish 
voluntary standards and labels relevant to their markets. With almost no exceptions, they 
introduced de facto regulation by introducing "zero-tolerance" to GM ingredients. Zero 
tolerance standards led to the reformulation of processed foods to remove biotechnology 
products or their derivatives and to identify traceable supply chains to ensure the absence of 
such products. Thus, the voluntary GMO-free standards have quickly become the benchmark, 
making other standards and regulation mechanisms irrelevant. Ramón et al (2004) suggest 
that the “requirement established … for detailed environmental risk evaluation of GM foods, 
as well as for their labelling and traceability to the marketplace, should avoid the polemics 
regarding safety and labelling, which have been evident within the European Union.” 
Moreover, they believe that the opportunity for the Council of Ministers to use a qualified 
majority for the approval or rejection of a GMO should override the de facto moratorium 
currently exercized by some member states. 
 
The reaction to GM soyabeans revealed the lack of demand in Europe for GM foods. This  is 
perhaps the highest barrier to biotechnology innovation for the food and drink industry. Lack 
of demand results from public anxiety about foods derived from GMOs or based on the 
genetic modification of animals. The public is  worried about the impact of GMOs on the 
environment and on human health, and on the possibility of animals suffering as a result of 
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genetic modification (Straughan, 1995). Gaskell et al (2000) suggest that regulation and 
public opinion co-evolved in Europe and US. In the EU, increased regulatory oversight 
coincided with growing negative public opinion about agro-biotechnology and diminishing 
trust in public authorities and regulatory agencies. Public scepticism about regulation was 
reinforced by crises like BSE and foot and mouth disease. There was also growing distrust of 
methods used to produce foods in the agro-food and agricultural sectors - the  use of 
pesticides, growth hormones or factory farming – and a growth in demand for organic foods.  
 
Several studies have been conducted across Europe to gauge public perceptions to 
biotechnology. Over time, public opposition to food biotechnology has grown, especially 
between 1996 and 1999. The level of opposition to GM foods was lowest in The Netherlands, 
Finland and Spain. By 2002 opposition stabilized across Europe as a whole. The public thinks 
GM foods have no consumer benefits, and therefore are not prepared to accept any risks 
associated with them. By 2002, in a few countries there was evidence of slight growth in 
public acceptance of the GM foods, and tolerance of risk, so long as there were consumer 
benefits (Durant et al, 1998; Gaskell et al, 2000; Gaskell et al, 2003). Other recent work also 
suggests that the climate of public opinions toward GM foods may be softening. A Delphi 
survey found that experts  
 
"expect …a kind of 'habituation' of the consumer to this type of product in around ten 
years. In this context, food products which offer clear benefits to the consumer are 
best suited for taking the lead … .   One example are [sic] probiotic foods17 or other 
food products supporting health requirements." (Menrad et al, 1999) 
                                                 
17 Probiotic foods are also known as neutraceuticals or functional foods. 
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A consumer survey conducted in Belgium in 2000 confirmed that consumer acceptance of 
GM food is positively influenced toward those with health benefits. There were also positive 
attitudes toward food with environmental or price benefits (Verdurme et al, 2003). 
 
The next section provides some information about the extent to which European companies 
are exploiting biotechnology. It reviews both the results of a European study, which 
examined biotechnology development in eight European countries, as well as more detailed, 
up-to-date information about the biotechnology activities of food firms in two small 
countries. 
 
5 Current Biotechnology Activities in the Food and Drink Sector 
This section, about the current biotechnology activities of the European food and drink 
sector shows that companies are very attentive to public attitudes in their exploitation of 
biotechnology. The EBIS project (Senker et al, 2001) provides information about the 
industrial exploitation of biotechnology in three sectors18 and in eight countries: Austria, 
France, Germany, Greece, Ireland, The Netherlands, Spain and the UK. The information on 
the agro-food sector is drawn from an analysis of the database of firms active in 
biotechnology in the eight countries.19 The EBIS project defined the term agro-food 
biotechnology as the application of biotechnology both to agriculture (seed and 
                                                 
18 The biopharmaceuticals, agro-food and research equipment and supplies sectors. 
19 Relevant companies in each country were identified from directories, media reports, government ministries 
and the Internet. Details about their activities relied on a variety of sources including use of a questionnaire, and 
material from a variety of secondary sources. The survey was carried out in 1999-2000. 
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agrochemical firms), and to food production (for control processes or diagnostics). The 
breakdown of firms by sub-sector is based on the firms’ main market. 
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Table 2: Breakdown of firms by sub-sector  
No. of firms by sector 
 
Austria 
 
Germany
 
France
 
Greece
 
Ireland
The 
Netherlands
 
Spain 
 
UK 
 
Total 
Agro-food biotech 3 20 59 12 6 34 22 6 162 
Biopharmaceuticals 13 71 88 4 14 29 21 98 338 
Research equipment 
and supplies20 
3 54 22 0 3 33 6 103 224 
Total 19 145 169 16 23 96 49 207 724 
 
Table 2, the number of firms in each sector, shows that the agro-food sector is the smallest 
of the three sectors (162 firms). The low number of firms involved in agro-food 
biotechnology may be caused by unwillingness to identify themselves as players in the 
biotechnology sector because of negative consumer attitudes. Some may be involved in 
research but waiting to exploit it when public attitudes are more favourable.  
 
The results may also be affected by different conceptions of what constitutes agro-food 
biotechnology. At its most limited, this would include only firms in the core of the sector. 
Firms that are suppliers of biotechnology products to the agro-food sector would be 
excluded because their core activity is in other sectors, such as pharmaceuticals, fine 
chemicals or services. A broader approach would include firms that provide services for the 
agro-food sector, like those involved in diagnostics or in the production of diagnostic kits.  
 
                                                 
20 This sector provides the instrumentation, materials and services necessary for undertaking biotechnology 
research.  
 24
Our analysis also showed that the firms in the agro-food sector were older and larger than in 
the other two sectors and also included the highest proportion of subsidiaries. These 
subsidiaries may act principally as suppliers to their parent companies. Almost every firm is 
involved in R&D collaborations, mainly with domestic and European partners. The finding 
that collaborations with public sector partners predominate over those with other firms 
mirrors the findings of the analysis by Valentin and Jensen (2003) of lactic acid bacteria 
patents (see section 2 above).  
 
An analysis of the factors affecting innovation in the sector found that public sector 
biotechnology research related to agriculture and agro-food received much lower funding 
than that in the biopharmaceuticals area. Moreover, most of relevant research was funded by 
public (national or the EC) sources. Germany, France and The Netherlands make the largest 
investment in public sector research and mainly focus on plant biotechnology. Spanish agro-
food biotechnology research is growing in strength. The UK and Ireland also invest in plant 
biotechnology and plant science but these investments do not generate commercial activity.  
 
Industrial activity is strongest in Germany, France and The Netherlands, partly due to the 
activities of large, domestic multinational companies and their subsidiaries. France, The 
Netherlands and Spain also have the most small biotechnology firms in the sector. In the 
latter two countries, this could be due to the strong agricultural traditions of these countries, 
together with muted public opposition to agro-food applications of biotechnology. The small 
number of agro-food biotechnology firms in the UK is difficult to explain. The UK has a 
strong science base in the area and there is a national emphasis on commercialising that 
science base. The campaigns of public interest groups, reinforced by media coverage and the 
response of concentrated food retailers appear to have created an environment where venture 
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capital is loathe to invest in these firms. Alternatively those companies that are involved may 
not be prepared to admit that they are active in the area.  
 
To sum up, the development of the agro-food biotechnology sector faces considerable 
barriers. The countries best placed to develop their competences are France and The 
Netherlands, based on their science base, their multinational companies and, in The 
Netherlands, muted public opposition to GMOs. Spain's fast-growing science base, and 
relative lack of public opposition to GMOs gives it the potential to develop national strength. 
The main brake on the development of food biotechnology, however, is the weakness of 
private investment in R&D, together with non-availability of venture capital to support the 
formation of small firms. In that respect, it is crucial for there to be greater awareness of the 
important role that public policy can play in supporting agro-food biotechnology research and 
use, especially development of the scientific knowledge base, evolution of technology 
transfer mechanisms and finally, policy to promote public acceptance of a reasonable use of 
biotechnology.  
 
There is very little  recent information about how food companies in Europe are now 
exploiting biotechnology. However, surveys of biotechnology firms in Finland and Ireland 
were undertaken during 2004. These countries are by no means representative of EC member 
states as a whole, but the information about how their food companies are exploiting 
biotechnology may provide clues to more general trends that may be emerging.  
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5.1 Finland:21 A survey of biotechnology firms in Finland found that eighteen, out of 
approximately 110-120 identified, were involved in the food sector in some way. Of these, 
five are multinational companies or their subsidiaries: one is involved in ingredients and 
functional foods, another is in functional food only, one is in enzymes and food ingredients, 
one is in food ingredients only and one is in enzymes only. The thirteen remaining firms are 
all DBFs. Three are involved in diagnostics, five are in functional food, three provide R&D 
services to the food sector and two are involved in supplying food ingredients. One of these 
DBFs specializes in ingredients for functional food. It is interesting to note the medical 
interests of three of these companies. Pharmaceutical companies are the main customers of 
one of the firms supplying R&D services, and a second company's products are specialized 
foods for hospital patients, designed to lower infection. The third company, involved in 
functional food, has recently merged with a drug development company. 
 
5.2  Ireland:22  The agro-food sector forms a major part of the Irish economy but, until 
recently, there was little exploitation of biotechnology. Since 2000 the government has 
launched several initiatives to promote the diffusion of biotechnology to the food sector 
(Burke et al, 2001). An analysis of Irish biotechnology companies listed by BioResearch 
Ireland, a government agency that promotes biotechnology research and its 
commercialisation, identified nine companies involved in aspects of biotechnology relevant 
to the food sector. One Irish multinational, the fourth largest dairy company in Europe, began 
                                                 
21 Private communication from T. Luukkonen, The Research Institute of the Finnish Economy (ETLA), 
Helsinki, based on ETLA database of Finnish biotechnology firms. 
22 Based on Burke et al (2001) and a list of companies supplied by BioResearch Ireland to the first author in 
2001, which has been updated via BioResearch Ireland’s website at 
http://www.biotechnologyireland.com/default.asp 
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work on a new Irish R&D facility in 2004. It will focus on developing ingredients for 
functional foods and plans to work closely with Irish academic researchers and biotechnology 
companies (Enterprise Ireland, 2003). Ireland is also home to a subsidiary of a US food 
ingredients MNC and its European biotechnology R&D centre. One former DBF, now part of 
a privately-owned group of firms, develops systems to treat industrial effluents, including 
those of food companies. Three DBFs are involved in diagnostics: one provides diagnostic 
kits and materials for the food and drink industry, another provides diagnostic kits and testing 
services and the third provides testing services only.  The other three DBFs are all involved in 
producing ingredients for functional foods and all focus on probiotic products to ameliorate 
medical conditions. For instance, one provides an anti-microbial ingredient suitable for 
medical foods and nutrition. 
 
6 Conclusions 
This chapter has reviewed the opportunities and barriers to biotechnology innovation in the 
European food and drink sector. It has shown that science based innovations are not central to 
the sector and, at present, biotechnology applications are not part of the core innovation 
process for the food and drink sector. Application is held back by lack of economic 
incentives, regulatory uncertainty and consumer opposition to GM. 
 
However, there are indications that biotechnology innovation in the food and drink sector will 
make slow progress in the next five to ten years, especially in diagnostics, process 
improvements or intermediate products (e.g. enzymes and other food ingredients) for the food 
and drink sector. However, these innovation will mainly come from companies in industrial 
sectors that act as suppliers to the food sector. Multinational companies will continue to build 
up their expertise in biotechnology so as to be able understand the advantages of new 
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products and processes offered to them by suppliers and to be able to exploit the market when 
market conditions become more favourable. In due course, successful experiments with 
functional foods may give food and drink companies greater confidence to apply 
biotechnology to the development of other products with clear consumer benefits. 
 
Public policy has a role to play in supporting the adoption of biotechnology by the European 
food and drink industry. Firstly, there is need for continued national and EC funding of public 
sector research related to food biotechnology, even though this knowledge is not currently 
being exploited by industry. Supporting public sector research will enable European scientists 
to have the expertise to operate in international networks and, in time, will provide the 
qualified scientists and engineers for companies that wish to exploit biotechnology.  It will 
also provide governments with the expertise to assess the risks associated with worldwide 
developments and to participate in international negotiations – as well as capturing spillovers 
from external knowledge. 
 
To ensure public confidence in food biotechnology, however, it is not sufficient to build up 
research capabilities, it is also necessary to invest in systematic bio-safety research and 
testing capabilities for novel foods and ingredients. This will provide a framework for 
communicating to the public about safe and beneficial applications of biotechnology.  
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